Zhiqiang Liu

Popular Topics

DETAILS

United States

+1 212 3362000

AUTHORS CONTENT

Impact Of Nautilus On Biotech And Pharmaceutical Patents

United States Healthcare

Biosimilar Makers' IPR Strategy Yields Mixed Results

United States Healthcare

New Targets In The Crosshairs: A Forum To Invalidate Patents Is Now Being Used On Biotech Firms

United States IP

Biosimilar Makers Turn To IPRs Before Litigation Under The BPCIA

United States Healthcare

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More